SWSophia J. Wu

Sophia J. Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sophia J. Wu has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Chiral oxazolidinones via biocatalytic aziridination of unactivated alkenes

    by Zi-Qi Li, Deirdre Hanley, Yu Zhang, Pei-Pei Xie, Sophia J. Wu, Zi-Yang Qin, Chi Zhang, Edwin Alfonzo, Francesca-Zhoufan Li, Sabine Brinkman-Chen, et al.


  • Biocatalytic, enantioenriched primary amination of tertiary C–H bonds

    by Runze Mao, Shilong Gao, Zi-Yang Qin, Torben Rogge, Sophia J. Wu, Zi-Qi Li, Anuvab Das, K. N. Houk, Frances H. Arnold

    Intermolecular functionalization of tertiary C–H bonds to construct fully substituted stereogenic carbon centres represents a formidable challenge: without the assistance of directing groups, state-of-the-art catalysts struggle to introduce chirality to racemic tertiary sp3-carbon centres. Direct asymmetric functionalization of such centres is a worthy reactivity and selectivity goal for modern biocatalysis. Here we present an engineered nitrene transferase (P411-TEA-5274), derived from a bacterial cytochrome P450, that is capable of aminating tertiary C–H bonds to provide chiral α-tertiary primary amines with high efficiency (up to 2,300 total turnovers) and selectivity (up to >99% enantiomeric excess). The construction of fully substituted stereocentres with methyl and ethyl groups underscores the enzyme’s remarkable selectivity. A comprehensive substrate scope study demonstrates the biocatalyst’s compatibility with diverse functional groups and tertiary C–H bonds. Mechanistic studies explain how active-site residues distinguish between the enantiomers and enable the enzyme to perform this transformation with excellent enantioselectivity.


  • Biocatalytic, stereoconvergent alkylation of (Z/E)-trisubstituted silyl enol ethers

    by Runze Mao, Doris Mia Taylor, Daniel J. Wackelin, Torben Rogge, Sophia J. Wu, Kathleen M. Sicinski, K. N. Houk, Frances H. Arnold

    The selective conversion of mixtures of Z/E alkenes into chiral products is a synthetic challenge. Biocatalytic strategies can transform isomeric alkenes into stereopure compounds, but enzymes typically convert only one alkene isomer, limiting the overall yield. Additional strategies have been used to interconvert alkene isomers, often at the cost of increasing energy consumption and chemical waste. Here we present engineered haemoproteins derived from a bacterial cytochrome P450 that efficiently catalyse α-carbonyl alkylation of isomeric silyl enol ethers, producing stereopure products. Through screening and directed evolution, we generated P450BM3 variant P411-SCA-5188, which catalyses stereoconvergent carbene transfer in Escherichia coli with high efficiency and stereoselectivity to various Z/E mixtures of silyl enol ethers. In contrast to established stereospecific transformations that leave one isomer unreacted, P411-SCA-5188 converts both isomers to a stereopure product. This biocatalytic approach simplifies the synthesis of chiral α-branched ketones by eliminating the need for stoichiometric chiral auxiliaries, strongly basic alkali-metal enolates and harsh conditions, delivering products with high efficiency and excellent chemo- and stereoselectivities.